AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters.
AMA CXO Todd Unger dives into new developments from ACIP’s emergency meeting on Feb. 4 with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.
AMA president Gerald Harmon, MD, welcomes experts from the U.S. Food and Drug Administration (FDA) to discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. Alternative treatment options for high-risk outpatients with mild-moderate COVID-19 are also discussed.
Guest: John Farley, MD, MPH, director, Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA
AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering new data coming from the CDC solidifying wearing high-quality N95 and KN95 masks provide the best chance of avoiding infection, as well as the addition of a new data point to the CDC’s COVID data tracker.
AMA CXO Todd Unger is joined by the AMA’s president, Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares new information and big takeaways about therapeutics for COVID-19 after his recent conversation with three physician leaders from the FDA.
AMA CXO Todd Unger talks with David Rubin, MD, director of PolicyLab at Children’s Hospital of Philadelphia and a professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, about his team’s nationally recognized COVID-19 forecasting model and how it informs new guidance for K-12 educational settings aimed at keeping kids in school.
AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Including the new “stealth Omicron” variant, as well as data from the latest CDC study showing third doses/booster shots bolster COVID defenses for both the immunocompromised and people with stronger immune systems. Also recapping AMA’s joint statement with the American Hospital Association (AHA) and the American Nurses Association (ANA) on blood shortages.
AMA CXO Todd Unger talks with AMA President Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., about the important role physicians can play at this pivotal time in the pandemic and the support they need to do so.
AMA CXO Todd Unger talks with Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston, to learn about his new COVID vaccine and how it fits into our global pandemic response.
During #DataPrivacyWeek, AMA CXO Todd Unger talks with Laura Hoffman, JD, the AMA’s assistant director of federal affairs, about the importance of establishing guardrails for digital vaccination data and how physicians can address data privacy concerns with patients.
Access the AMA’s case for privacy by design in app development resource here: https://www.ama-assn.org/system/files/privacy-principles-by-design.pdf
To learn more about AMA’s health data privacy framework and advocacy work on the issue, visit: https://www.ama-assn.org/delivering-care/patient-support-advocacy/ama-health-data-privacy-framework